Black Hawk Acquisition Corp(BKHA) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | 148.93 | EPS (ttm) | 0.08 | Insider Own | 11.47% | Shs Outstand | 4.2M | Perf Week | -0.88% |
| Market Cap | 0.05B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 3.7M | Perf Month | 0.89% |
| Enterprise Value | 0.05B | PEG | - | EPS next Q | - | Inst Own | 47.06% | Short Float | - | Perf Quarter | -0.04% |
| Income | 0.00B | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | 0.02 | Perf Half Y | 2.63% |
| Sales | 0.00B | P/B | 2.44 | EPS next 5Y | - | ROA | 0.77% | Short Interest | 0.00M | Perf YTD | 5.64% |
| Book/sh | 4.87 | P/C | 4901.94 | EPS past 3/5Y | - | ROE | 0.83% | 52W High | -9.27% ($13.10) | Perf Year | 7.56% |
| Cash/sh | 0 | P/FCF | - | Sales past 3/5Y | - | ROIC | 1.88% | 52W Low | 8.05% ($11.00) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -74.68% | Gross Margin | - | Volatility(W/M) | - 0.54% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.13 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.02 | EPS Q/Q | -63.29% | Profit Margin | - | RSI (14) | 48.11 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.02 | Sales Q/Q | - | SMA20 | -0.22% ($11.92) | Beta | 0.04 | Target Price | - |
| Payout | - | Debt/Eq | 0.13 | Earnings | - | SMA50 | 0.1% ($11.88) | Rel Volume | 0.01 | Prev Close | $11.97 |
| Employees | 2 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | 7.86% ($11.02) | Avg Volume(3M) | 0.00M | Price | $11.89 |
| IPO | 2024/5/13 | Option/Short | No/Yes | Trades | 5 | Volume | 14 | Change | -0.71% |
Company
BKHA is a Financial sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🦅 Black Hawk Acquisition () is a SPAC established to acquire companies with growth potential and defensive market positions. In 2025, it entered into a merger agreement with Vesicor Therapeutics, and upon completion of the merger, it is expected to trade on Nasdaq under the ticker symbol 'VESI'.
Over the past 1 year, roughly in the middle
9% below its 1-year high.
BKHA has weak earning power
Tap to view numbers
The price looks about right
Trading at 148.9 times earnings.
Tap to view numbers
Long-term returns are close to the market
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 47.1%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
CUSD 0.00%
RAM 0.00%
RNMN 0.00%
SPCZ 0.00%
SPAQ 0.00%It ranks #4 in the industry
Based on market cap of $49M.
BKHA $49M PER 148.9
LION $3B PER -
BBCQ $2B PER -
CCXI $714M PER -
FAQ
What kind of company is BKHA?
BKHA belongs to the Financial sector and operates in the Shell Companies industry.
What is the market cap of BKHA?
The market cap of BKHA is approximately $49M, ranking 4,945 within its sector.
What is the P/E ratio of BKHA?
BKHA has a P/E ratio of approximately 148.9x, which can be used to assess its valuation relative to the Financial sector average.
What is the 52-week high and low for BKHA?
BKHA has recorded a 52-week high of $13.10 and a low of $11.00.
